Dexmedetomidine hydrochloride
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride is a prescription injectable solution used for short-term sedation in intensive care settings. It works as an alpha-2 adrenergic agonist to provide calming effects during procedures or mechanical ventilation. Administered intravenously at 4 mcg/mL strength in 50 mL or 100 mL bottles, it's approved as a generic drug by Sagent Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dexmedetomidine hydrochloride
Access the FDA dataset for Dexmedetomidine hydrochloride β ANDA 209307 submitted by Mylan Institutional LLC
Modified Mar 24, 2026